21 May 2013
Keywords: novo, expands, rights, aradigm, aerx, idms, danish
Article | 04 October 2004
Danish drugmaker Novo Nordisk says it has extended its existing agreement with the USA's Aradigm Corp to obtain full development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
11 October 2004
20 May 2013
© 2013 thepharmaletter.com